[Comparative anti-inflammatory action of anticoagulant substances. Mode of action of phenylindanedione].
D000311:Adrenal Glands / Q000502:physiology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002351:Carrageenan / Q000009:adverse effects; D003374:Coumarins / Q000627:therapeutic use*; D001728:Dicumarol / Q000627:therapeutic use*; D004487:Edema / Q000188:drug therapy; D010630:Phenindione / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000627:therapeutic use*; D011833:Radiation Injuries, Experimental / Q000188:drug therapy; D051381:Rats; D014859:Warfarin / Q000627:therapeutic use*; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D003374:Coumarins; D062367:ortho-Aminobenzoates; D010630:Phenindione; D014859:Warfarin; D001728:Dicumarol; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin
Activité anti-inflammatoire comparée de substances anticoagulantes. Mode d'action de la phénylindanedione.